Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PLXS
|
Ronnie Darroch
EVP Global Ops & Reg Pres-EMEA |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 23.28% |
$161,960
$80.98 p/Share
|
Feb 18
2021 |
|
AGM
|
Zions Bancorporation, National Association /Ut/
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 8.0% |
$840,200
$84.02 p/Share
|
Feb 18
2021 |
|
TVTX
|
William E. Rote
Chief Research Officer |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 3.46% |
$35,838
$28.67 p/Share
|
Feb 18
2021 |
|
LOV
|
Canaan Viii LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.29% |
$66,900
$6.69 p/Share
|
Feb 18
2021 |
|
SCHW
|
Charles R. Schwab
Co-Chairman |
SELL
Open market or private sale
|
Indirect | 70,000 Reduced 0.04% |
$4,263,700
$60.91 p/Share
|
Feb 18
2021 |
|
IP
|
Jean Michel Ribieras
Senior Vice President |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 19.65% |
$719,700
$47.98 p/Share
|
Feb 18
2021 |
|
IP
|
W. Michael Amick Jr.
Senior Vice President |
SELL
Open market or private sale
|
Direct | 18,222 Reduced 44.0% |
$875,203
$48.03 p/Share
|
Feb 18
2021 |
|
UMBF
|
James Cornelius
Executive Vice President |
SELL
Open market or private sale
|
Direct | 786 Reduced 11.57% |
$62,408
$79.4 p/Share
|
Feb 18
2021 |
|
FIBK
|
Julie A Scott
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 628 Reduced 100.0% |
$27,525
$43.83 p/Share
|
Feb 18
2021 |
|
NUS
|
Joseph Y Chang
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 1,125 Reduced 5.57% |
$55,991
$49.77 p/Share
|
Feb 18
2021 |
|
MDRX
|
Lisa Khorey
Chief Client Delivery Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 5.96% |
$251,250
$16.75 p/Share
|
Feb 18
2021 |
|
ECOM
|
Timothy Buckley
Director |
SELL
Open market or private sale
|
Direct | 17,500 Reduced 16.14% |
$449,400
$25.68 p/Share
|
Feb 18
2021 |
|
EDSA
|
Frank R. Oakes |
SELL
Open market or private sale
|
Indirect | 1,827 Reduced 100.0% |
$13,246
$7.25 p/Share
|
Feb 18
2021 |
|
EDSA
|
Frank R. Oakes |
SELL
Open market or private sale
|
Direct | 6,165 Reduced 100.0% |
$44,696
$7.25 p/Share
|
Feb 18
2021 |
|
LOVE
|
Andrew R Heyer
Director |
SELL
Open market or private sale
|
Indirect | 105,000 Reduced 1.38% |
$5,670,000
$54.0 p/Share
|
Feb 18
2021 |
|
CLDR
|
Robert G Bearden
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 112,384 Reduced 100.0% |
$2,054,380
$18.28 p/Share
|
Feb 18
2021 |
|
PTNL
|
Christian Machado
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 26,000 Reduced 0.29% |
$2,600
$0.1 p/Share
|
Feb 18
2021 |
|
PTNL
|
Adrian A Bray
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 26,000 Reduced 0.17% |
$2,600
$0.1 p/Share
|
Feb 18
2021 |
|
MARA
|
Merrick D Okamoto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 700,000 Reduced 15.47% |
$34,055,001
$48.65 p/Share
|
Feb 18
2021 |
|
BLFS
|
Karen A. Foster
Chief Quality and Operations |
SELL
Open market or private sale
|
Direct | 3,353 Reduced 4.47% |
$136,367
$40.67 p/Share
|
Feb 18
2021 |
|
BLFS
|
Aby J. Mathew
EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 4,741 Reduced 2.22% |
$192,816
$40.67 p/Share
|
Feb 18
2021 |
|
BLFS
|
Michael Rice |
SELL
Open market or private sale
|
Direct | 10,132 Reduced 3.73% |
$412,068
$40.67 p/Share
|
Feb 18
2021 |
|
BLFS
|
Todd Berard
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 1,882 Reduced 2.39% |
$76,541
$40.67 p/Share
|
Feb 18
2021 |
|
BLFS
|
Roderick De Greef
President and CEO |
SELL
Open market or private sale
|
Direct | 4,520 Reduced 2.4% |
$183,828
$40.67 p/Share
|
Feb 18
2021 |
|
PRTA
|
Wagner M. Zago
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 7,540 Reduced 100.0% |
$192,270
$25.5 p/Share
|
Feb 18
2021 |
|
LH
|
Peter J Wilkinson
SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,317 Reduced 87.11% |
$559,579
$241.51 p/Share
|
Feb 18
2021 |
|
MNTV
|
John S Schoenstein
Chief Sales Officer |
SELL
Open market or private sale
|
Direct | 9,598 Reduced 6.2% |
$207,797
$21.65 p/Share
|
Feb 18
2021 |
|
MNTV
|
Deborah Clifford
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,988 Reduced 1.86% |
$108,040
$21.66 p/Share
|
Feb 18
2021 |
|
INFN
|
Nicholas Walden
SVP, Worldwide Sales |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 19.47% |
$30,930
$10.31 p/Share
|
Feb 18
2021 |
|
INFN
|
Michael H Fernicola |
SELL
Open market or private sale
|
Direct | 2,589 Reduced 100.0% |
$26,693
$10.31 p/Share
|
Feb 18
2021 |
|
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.13% |
$1,718,000
$171.8 p/Share
|
Feb 18
2021 |
|
IRDM
|
Thomas Fitzpatrick
Director |
SELL
Open market or private sale
|
Direct | 170,590 Reduced 64.89% |
$8,004,082
$46.92 p/Share
|
Feb 18
2021 |
|
RBB
|
Chuang I Lin
Director |
SELL
Open market or private sale
|
Direct | 10,763 Reduced 30.5% |
$201,053
$18.68 p/Share
|
Feb 18
2021 |
|
RBB
|
Ko Yen Lin |
SELL
Open market or private sale
|
Direct | 10,763 Reduced 9.23% |
$201,053
$18.68 p/Share
|
Feb 18
2021 |
|
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 42,408 Reduced 0.73% |
$920,254
$21.7 p/Share
|
Feb 18
2021 |
|
GTE
|
Gmt Capital Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 161,100 Reduced 0.35% |
$149,823
$0.93 p/Share
|
Feb 18
2021 |
|
PLTR
|
Peter Thiel
Director |
SELL
Open market or private sale
|
Indirect | 20,003,915 Reduced 51.49% |
$509,899,789
$25.49 p/Share
|
Feb 18
2021 |
|
EFF
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 159,926 Reduced 10.68% |
$2,514,037
$15.72 p/Share
|
Feb 18
2021 |
|
NOW
|
Fay Sien Goon
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 139 Reduced 3.44% |
$79,559
$572.37 p/Share
|
Feb 18
2021 |
|
NOW
|
Chirantan Jitendra Desai
President & COO |
SELL
Open market or private sale
|
Direct | 6,146 Reduced 14.06% |
$3,502,974
$569.96 p/Share
|
Feb 18
2021 |
|
VRTX
|
Paul M Silva
SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 4,295 Reduced 20.33% |
$908,392
$211.5 p/Share
|
Feb 18
2021 |
|
VRTX
|
Amit Sachdev
EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct | 9,264 Reduced 16.56% |
$1,960,540
$211.63 p/Share
|
Feb 18
2021 |
|
VRTX
|
Michael Parini
EVP, Chief Adm, Leg & BD Off |
SELL
Open market or private sale
|
Direct | 7,825 Reduced 17.74% |
$1,658,743
$211.98 p/Share
|
Feb 18
2021 |
|
VRTX
|
Stuart A Arbuckle
EVP, COO |
SELL
Open market or private sale
|
Direct | 7,825 Reduced 14.11% |
$1,658,039
$211.89 p/Share
|
Feb 18
2021 |
|
VRTX
|
David Altshuler
EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 7,825 Reduced 16.7% |
$1,658,509
$211.95 p/Share
|
Feb 18
2021 |
|
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.23% |
$1,488,000
$74.4 p/Share
|
Feb 18
2021 |
|
TYL
|
John S Marr Jr
Executive Chair of the Board |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 9.73% |
$4,678,100
$467.81 p/Share
|
Feb 18
2021 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 12,001 Reduced 0.06% |
$3,023,532
$251.94 p/Share
|
Feb 18
2021 |
|
ZG
|
Aimee Johnson
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 12,375 Reduced 19.58% |
$2,270,441
$183.47 p/Share
|
Feb 18
2021 |
|
ARW
|
Michael J Long
Executive Chairman |
SELL
Open market or private sale
|
Direct | 97,249 Reduced 36.17% |
$10,049,711
$103.34 p/Share
|
Feb 18
2021 |